![PRD_002337 PRD_002337](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002337.svg) | PRD_002337 | Name: | INHIBITOR ARC-1411 | Formula: | C61 H119 N34 O9 | Definition date: | 2024-04-10 | Last modified: | 2024-04-10 |
|
![PRD_002339 PRD_002339](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002339.svg) | PRD_002339 | Name: | Inhibitor ARC-1415 | Formula: | C55 H106 N30 O8 | Definition date: | 2024-04-10 | Last modified: | 2024-04-10 |
|
![PRD_002532 PRD_002532](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002532.svg) | PRD_002532 | Name: | N-Methyl-D-Gln4,Lys10-teixobactin | Formula: | C59 H100 N13 O15 | Definition date: | 2024-03-06 | Last modified: | 2024-03-06 |
|
![PRD_002557 PRD_002557](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002557.svg) | PRD_002557 | Name: | Stapled peptide | Formula: | C80 H104 N27 O17 | Definition date: | 2024-03-06 | Last modified: | 2024-03-06 |
|
![PRD_002559 PRD_002559](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002559.svg) | PRD_002559 | Name: | Stapled peptide | Formula: | C75 H105 N26 O17 | Definition date: | 2024-03-06 | Last modified: | 2024-03-06 |
|
![PRD_002533 PRD_002533](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002533.svg) | PRD_002533 | Name: | Deacylated Microviridin J | Formula: | C67 H97 N17 O20 | Definition date: | 2024-02-14 | Last modified: | 2024-02-14 |
|
![PRD_002473 PRD_002473](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002473.svg) | PRD_002473 | Name: | Agrocinopine A (beta-L-arabinopyranose form) | Formula: | C17 H31 O18 P | Description: | phosphodiester of sucrose and L-arabinose | Definition date: | 2024-01-24 | Last modified: | 2024-01-24 |
|
![PRD_002485 PRD_002485](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/UKU.svg) | PRD_002485 | Name: | [(2S,3R,4S,5S,6R)-6-(hydroxymethyl)-2,4,5-tris(oxidanyl)oxan-3-yl]oxy-N-[9-[(2R,3S,5R)-5-[[[(2R,3S)-4-methyl-2,3-bis(oxidanyl)pentanoyl]amino]-oxidanyl-phosphoryl]oxy-3-oxidanyl-oxolan-2-yl]purin-6-yl]phosphonamidic acid | Formula: | C21 H34 N6 O16 P2 | Description: | unusual glycan purine conjugate (containing GLC and ADE) | Definition date: | 2024-01-24 | Last modified: | 2024-01-24 |
|
![PRD_002506 PRD_002506](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002506.svg) | PRD_002506 | Name: | Agrocinopine C-like (D-glucos-2-yl sucros-4-yl phosphate; alpha-D-glucose form) | Formula: | C18 H33 O19 P | Description: | Phosphodiester of D-alpha-glucose (ALX) and sucrose (GLC-FRU). | Definition date: | 2024-01-24 | Last modified: | 2024-01-24 |
|
![PRD_002507 PRD_002507](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002507.svg) | PRD_002507 | Name: | Agrocinopine C-like (D-glucos-2-yl sucros-3-yl phosphate; alpha-D-glucose form) | Formula: | C18 H33 O19 P | Description: | Phosphodiester of D-alpha-glucose (ALX) and sucrose (GLC-FRU). | Definition date: | 2024-01-24 | Last modified: | 2024-01-24 |
|
![PRD_002508 PRD_002508](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002508.svg) | PRD_002508 | Name: | Agrocinopine C-like (D-glucos-2-yl sucros-3-yl phosphate; beta-D-glucose form) | Formula: | C18 H33 O19 P | Description: | Phosphodiester of D-beta-glucose (BNX) and sucrose (GLC-FRU). | Definition date: | 2024-01-24 | Last modified: | 2024-01-24 |
|
![PRD_002547 PRD_002547](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002547.svg) | PRD_002547 | Name: | Agrocinopine C-like (D-glucos-2-yl sucros-1-yl phosphate; alpha-D-glucose form) | Formula: | C18 H33 O19 P | Description: | Phosphodiester of D-alpha-glucose (ALX) and sucrose (GLC-FRU). | Definition date: | 2024-01-24 | Last modified: | 2024-01-24 |
|
![PRD_002548 PRD_002548](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002548.svg) | PRD_002548 | Name: | Agrocinopine C-like (D-glucos-2-yl sucros-1-yl phosphate; beta-D-glucose form) | Formula: | C18 H33 O19 P | Description: | Phosphodiester of D-beta-glucose (BNX) and sucrose (GLC-FRU). | Definition date: | 2024-01-24 | Last modified: | 2024-01-24 |
|
![PRD_002517 PRD_002517](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002517.svg) | PRD_002517 | Formula: | C66 H84 N10 O17 S | Definition date: | 2023-12-06 | Last modified: | 2023-12-06 |
|
![PRD_002466 PRD_002466](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002466.svg) | PRD_002466 | Name: | Cyclohexyl-Griselimycin | Formula: | C63 H106 N10 O12 | Definition date: | 2023-11-29 | Last modified: | 2023-11-29 |
|
![PRD_002467 PRD_002467](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002467.svg) | PRD_002467 | Name: | Mycoplanecin A | Formula: | C61 H102 N10 O13 | Definition date: | 2023-11-29 | Last modified: | 2023-11-29 |
|
![PRD_002417 PRD_002417](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002417.svg) | PRD_002417 | Name: | Ac-VRHA-conh-[4-(4-butyl)-phenoxy-1-phenyl-2-butyl] | Formula: | C43 H66 N10 O7 | Definition date: | 2023-10-25 | Last modified: | 2023-10-25 |
|
![PRD_002443 PRD_002443](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002443.svg) | PRD_002443 | Name: | SiaLac-amidine-Lys | Formula: | C33 H57 N5 O20 S | Definition date: | 2023-09-27 | Last modified: | 2023-09-27 |
|
![PRD_002387 PRD_002387](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/EJG.svg) | PRD_002387 | Name: | tert-butyl N-[5-phenyl-3-(2-phenylethylcarbamoyl)thiophen-2-yl]carbamate | Formula: | C24 H26 N2 O3 S | Definition date: | 2023-09-27 | Last modified: | 2023-09-27 |
|
![PRD_002426 PRD_002426](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002426.svg) | PRD_002426 | Name: | Corramycin | Formula: | C51 H81 N11 O21 | Definition date: | 2023-08-16 | Last modified: | 2023-08-16 |
|
![PRD_002431 PRD_002431](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002431.svg) | PRD_002431 | Name: | Cyclic tetraadenosine monophosphate (cA4) | Formula: | C40 H48 N20 O24 P4 | Description: | Cyclic oligoadenylates such as c-tetraAMP were found to be novel bacterial second messengers. Antiviral in context of signalling for Type III CRISPR-Cas systems. | Definition date: | 2023-07-12 | Last modified: | 2023-07-03 |
|
![PRD_002432 PRD_002432](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002432.svg) | PRD_002432 | Name: | Pam3-SKKKK | Formula: | C81 H160 N10 O13 S | Definition date: | 2023-07-12 | Last modified: | 2023-07-12 |
|
![PRD_002528 PRD_002528](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002528.svg) | PRD_002528 | Name: | 142D6 | Formula: | C26 H37 F N4 O6 S | Description: | Lys-covalent pan-IAP inhibitor | Definition date: | 2023-07-12 | Last modified: | 2023-07-12 |
|
![PRD_002527 PRD_002527](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002527.svg) | PRD_002527 | Name: | Intermediate for maxamycins synthesis | Formula: | C84 H114 Cl2 N8 O17 S Si2 | Definition date: | 2023-07-05 | Last modified: | 2023-07-05 |
|
![PRD_002484 PRD_002484](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/C84.svg) | PRD_002484 | Name: | [(2R,3R,4S,5S,6R)-6-(hydroxymethyl)-2,4,5-tris(oxidanyl)oxan-3-yl]oxy-N-[9-[(2R,3S,5R)-5-[[[(2R,3S)-4-methyl-2,3-bis(oxidanyl)pentanoyl]amino]-oxidanyl-phosphoryl]oxy-3-oxidanyl-oxolan-2-yl]purin-6-yl]phosphonamidic acid | Formula: | C21 H34 N6 O16 P2 | Description: | unusual glycan purine conjugate (containing BGC and ADE) | Definition date: | 2023-06-14 | Last modified: | 2023-06-14 |
|